Medpage Today on MSN2mon
FDA Approves New Option for RosaceaParticipants were randomized to either daily minocycline hydrochloride (40 mg); doxycycline, the current standard of care; or ...
Piramal Pharma said that its subsidiary Piramal Critical Care (PCC) has launched Chlorpromazine Hydrochloride for Injection in various strengths in the US market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results